Repeated administration of berberine inhibits cytochromes P450 in humans

Complementary and Alternative Medicine Use Among Adults and Children: United States, 2007

Patricia M. Barnes, Barbara Bloom, Richard L. Nahin · PsycEXTRA Dataset · 2008 · 3.2K citations

Public Health, Health Sciences, Adolescent Health +7

Pharmacokinetics of losartan and its metabolite E‐3174 in relation to the <i>CYP2C9</i> genotype

Ümit Yaşar, Cecilia Forslund‐Bergengren, Gunnel Tybring et al. · Clinical Pharmacology & Therapeutics · 2002 · 183 citations

Medicine, Pharmacokinetics, Pharmacology +11

St John's wort induces both cytochrome P450 3A4–catalyzed sulfoxidation and 2C19–dependent hydroxylation of omeprazole

Liansheng Wang, Gan Zhou, Bing Zhu et al. · Clinical Pharmacology & Therapeutics · 2004 · 145 citations

Medicine, Pharmacokinetics, Pharmacology +15

Development of the “Inje Cocktail” for High-throughput Evaluation of Five Human Cytochrome P450 Isoforms in vivo

Ji Young Ryu, Im‐Sook Song, Yu Eun Sunwoo et al. · Clinical Pharmacology & Therapeutics · 2007 · 130 citations

Medicine, Pharmacokinetics, Pharmacology +14

An <i>in vitro</i> Evaluation of Cytochrome P450 Inhibition and P-Glycoprotein Interaction with Goldenseal, <i>Ginkgo biloba</i>, Grape Seed, Milk Thistle, and Ginseng Extracts and Their Constituents

Amy S. Etheridge, Sherry R. Black, Purvi R. Patel et al. · Planta Medica · 2007 · 98 citations

Medicine, Pharmacokinetics, Pharmacology +17